MedPath

TOBRAMYCIN AND DEXAMETHASONE

Sterile

Approved
Approval ID

3c63c481-ce57-41ca-993f-5a5b665fa1e4

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 12, 2024

Manufacturers
FDA

Bryant Ranch Prepack

DUNS: 171714327

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

tobramycin and dexamethasone

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code63629-9570
Application NumberANDA212715
Product Classification
M
Marketing Category
C73584
G
Generic Name
tobramycin and dexamethasone
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateDecember 21, 2022
FDA Product Classification

INGREDIENTS (11)

DEXAMETHASONEActive
Quantity: 1 mg in 1 mL
Code: 7S5I7G3JQL
Classification: ACTIB
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
SODIUM SULFATEInactive
Code: 0YPR65R21J
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
SULFURIC ACIDInactive
Code: O40UQP6WCF
Classification: IACT
TYLOXAPOLInactive
Code: Y27PUL9H56
Classification: IACT
TOBRAMYCINActive
Quantity: 3 mg in 1 mL
Code: VZ8RRZ51VK
Classification: ACTIB
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7
Classification: IACT
HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%)Inactive
Code: S38J6RZN16
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TOBRAMYCIN AND DEXAMETHASONE - FDA Drug Approval Details